Safety and efficacy of etanercept therapy in ankylosing spondylitis patients undergoing phacoemulsification surgery.
Kemény-Beke
Adám
A
Szekanecz
Zoltán
Z
Szántó
Sándor
S
Bodnár
Nóra
N
Módis
László
L
Gesztelyi
Rudolf
R
Zsuga
Judit
J
Szodoray
Péter
P
Berta
András
A
D018501:Antirheumatic Agents / Q000009:adverse effects; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D018918:Phacoemulsification / Q000379:methods*; D012307:Risk Factors; D013167:Spondylitis, Ankylosing / Q000601:surgery*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha